Zinexts Launched Latest Innovation at MEDICA 2025

Zinexts concluded an impressive week at MEDICA 2025 from 17- 20 November 2025. Our team, General Manager Dr. Hartmut Goette, Business Development Manager Dr. Mathieu Gauthier, and Sales Manager Pony Shiao, joined the world’s largest medical trade fair, engaging with global partners and industry leaders.

Here are the key highlights from MEDICA 2025:

• NeXgen^TM 16HP Hits the Market

After rigorous development, NeXgen^TM 16HP was officially launched with IVDR certification at MEDICA 2025. The NeXgen^TM 16HP system has been widely recognized for its outstanding design and technology, receiving multiple prestigious honors including the Red Dot Design Concept Award 2024, Taipei Biotech Award 2025, and most recently, the Taiwan Excellence Gold Award 2026. These achievements highlight its exceptional system concept and proven technological performance.

Our fully automated, sample-to-result solution received remarkable attention and enthusiastic feedback from partners and visitors throughout the exhibition. With the final refinements now in place, NeXgen^TM 16HP is ready to expand its presence worldwide.

• Zinexts DataVerse^TM Coming Soon

One of the highlights of the show was the introduction of DataVerse^TM, our upcoming smart data integration and analysis ecosystem. The interactive demonstrations at our booth created great excitement and ensured a better understanding of the DataVerse^TM concept.

DataVerse^TM Core serves as a genomic and clinical data management system. It integrates Zinexts’ systems with existing LIS/LIMS/HIS for seamless data transfer and management. On top of that, the platform handles complex qPCR assay result interpretation and generates comprehensive clinical reports with actionable insights for clinicians. Working hand-in-hand with DataVerse^TM GQ, the system also incorporates NGS data results into complete clinical reports.

DataVerse^TM GQ is a powerful sequencing data analyzer. It analyzes sequencing data from all major sequencing platforms and handles various formats (FASTQ/VCF/BAM). The results can be exported in multiple formats or, combined directly with DataVerse^TM Core, can be utilized to issue comprehensive clinical reports.

Together, these platforms create a truly integrated Zinexts galaxy of diagnostic solutions.

• Networking & Market Insights
  

Beyond showcasing products, MEDICA 2025 gave us the chance to reconnect with partners, industry professionals, and new collaborators. These meaningful conversations, insights, and feedback shape how we innovate and advance the future of molecular diagnostics.

MEDICA 2025 represented something significant for Zinexts. This year, we showcased the complete diagnostic journey from sample collection, nucleic acid extraction, and qPCR detection, all the way to clinical data management and NGS data analysis unified within the DataVerse^TM network.

Last but not least, we sincerely appreciate your trust and support we received at MEDICA 2025. Stay connected with Zinexts with our latest developments and upcoming events in by subscribing to our newsletter and following us on LinkedIn.